M. K. Lo et al. , «GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses», Sci. Rep. , vol. 7, no. 1, p. 43395, Mar. 2017.
R. T. Eastman et al. , «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19», ACS Cent. Sci. , vol. 6, no. 5, pp. 672–683, May 2020.
A. Feuerstein, «Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment», STAT News , 16-Apr-2020.
«NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19», NIH , 29-Apr-2020.
J. H. Beigel et al. , «Remdesivir for the Treatment of Covid-19 — Preliminary Report», N. Engl. J. Med. , p. NEJMoa2007764, May 2020.
Y. Wang et al. , «Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial», Lancet , vol. 395, no. 10236, pp. 1569–1578, May 2020.
FDA, «Remdesevir Emergency Use Authorization for Potential COVID-19 Treatment», 01-May-2020.
«Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients», FUJIFILM Toyama Chemical Co., Ltd. , 23-Sep-2020.
Т. А. Руженцова et al. , «Возможности этиотропной терапии коронавирусной инфекции, вызванной SARS-CoV-2, у амбулаторных пациентов», Медицинский оппонент , vol. 1, no. 9, pp. 48–58, 2020.
Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.2020) // Министерство здравоохранения Российской Федерации, 2020. [Online]. Available: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf?fbclid=IwAR1p266v_Ok6Hw0Xjw5nRVtJopPRDKdpP1nEMDmDcvHl0ug9QZPo6-mV80c.
J. H. Beigel et al. , «Remdesivir for the Treatment of Covid-19 — Preliminary Report», N. Engl. J. Med. , p. NEJMoa2007764, May 2020.
«Руководство по лечению и поддерживающей терапии пациентов с коронавирусной инфекцией COVID-19, выпуск марта 2020 г»., ЛОМБАРДИЯ, SIMIT Итальянское Общество Инфекционных и Тропических болезней ОТДЕЛ РЕГИОНА . [Online]. Available: https://h-clinic.ru/upload/%D0%9D%D0%B5%D0%BE%D1%84%D0%B8%D1%86%D0%B8%D0%B0%D0%BB%D1%8C%D0%BD%D1%8B%D0%B8%CC%86%20%D0%BF%D0%B5%D1%80%D0%B5%D0%B2%D0%BE%D0%B4%20%D0%A0%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%B0%20%D0%BF%D0%BE%20%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8E%20%D0%BF%D0%B0%D1%86%D0%B8%D0%B5%D0%BD%D1%82%D0%BE%D0%B2%20%D1%81%2 °COVID-19%20%D0%B2%20%D0%98%D1%82%D0%B0%D0%BB%D0%B8%D0%B8.pdf.
O.-M. J. Benhamou, M. Jacobs, J. Drew, S. Geva, M. Waldman, and O. Kalchiem-Dekel, «The Use of Interferons in Respiratory Diseases», Curr. Respir. Med. Rev. , vol. 9, no. 5, 2013.
«COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines»., National Institutes of Health , 2020. [Online]. Available: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf. [Accessed: 21-Jun-2020].
«Management of a possible case of COVID-19. Version 13. Revised 31 July 2020», Public Health England , 2020. [Online]. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/906096/COVID-19_flow_chart.pdf. [Accessed: 04-Sep-2020].
T. Feldt and T. Guggemos, Wolfgang Heim, Katrin Klug, Bettina Lehnert, Regine Lübbert, Christoph Niebank, Michaela Pfäfflin, Frieder Rothfuss, Katja Schmiedel, Stefan Stegemann, Miriam S. Stich, August Wolf, «Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19. Stand: 06.08.2020», St ä ndiger Arbeitskreis der Kompetenz- und Behandlungszentren f ü r Krankheiten durch hochpathogene Erreger am Robert Koch-Institut , 2020.
«COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines»., National Institutes of Health , 2020. [Online]. Available: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf. [Accessed: 21-Jun-2020].
Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.2020) // Министерство здравоохранения Российской Федерации, 2020. [Online]. Available: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf?fbclid=IwAR1p266v_Ok6Hw0Xjw5nRVtJopPRDKdpP1nEMDmDcvHl0ug9QZPo6-mV80c.
L. Fardet, I. Petersen, and I. Nazareth, «Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study», PloS Med. , vol. 13, no. 5, p. e1002024, May 2016.
T. Feldt and T. Guggemos, Wolfgang Heim, Katrin Klug, Bettina Lehnert, Regine Lübbert, Christoph Niebank, Michaela Pfäfflin, Frieder Rothfuss, Katja Schmiedel, Stefan Stegemann, Miriam S. Stich, August Wolf, «Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19. Stand: 06.08.2020», Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger am Robert Koch-Institut , 2020.
«Clinical management of COVID-19: interim guidance 27 May 2020», WHO , 27-May-2020.
C. D. Russell, J. E. Millar, and J. K. Baillie, «Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury», Lancet , vol. 395, no. 10223, pp. 473–475, Feb. 2020.
The RECOVERY Collaborative Group, «Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report», N. Engl. J. Med. , p. NEJMoa2021436, Jul. 2020.
P. Horby et al. , «Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report», medRxiv , p. 2020.06.22.20137273, Jan. 2020.
«FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment, Another Achievement in Administration’s Fight Against Pandemic», FDA , 23-Aug-2020.
S. Pandey and G. N. Vyas, «Adverse effects of plasma transfusion», Transfusion , vol. 52, pp. 65S-79S, May 2012.
A. Agarwal et al. , «Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)», medRxiv , p. 2020.09.03.20187252, Jan. 2020.
Читать дальше
Конец ознакомительного отрывка
Купить книгу